More treatment options, targeted therapies and an understanding of when less is more have improved breast cancer outcomes in recent years. But more work remains.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
Researchers have found that a novel drug combination disrupts multiple factors in an aggressive type of breast cancer.
Surgeon attitudes were the biggest driver of likelihood that patients receive contralateral prophylactic mastectomy, a new study finds.
Researchers have developed a fluidic device to track over time which cancer cells lead the disease’s invasive march.
Worry about recurrence and radiation more often lead women to weigh double mastectomy.
DNA and RNA sequencing of 500 patients with solid tumors revealed potential treatment targets and opened the door to a deeper understanding of metastatic cancer.